Suppr超能文献

支气管肺泡灌洗在异基因 SCT 患者肺炎中的临床意义。

The clinical importance of bronchoalveolar lavage in allogeneic SCT patients with pneumonia.

机构信息

Department of Medicine, Division of Respiratory Medicine and Allergology, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

出版信息

Bone Marrow Transplant. 2010 May;45(5):945-50. doi: 10.1038/bmt.2009.268. Epub 2009 Sep 28.

Abstract

Patients who undergo allogeneic hematopoietic SCT (HSCT) are prone to pulmonary infections. Between 1998 and 2004, a total of 450 patients underwent HSCT at Karolinska University Hospital, Huddinge. Pneumonia was diagnosed in 167 patients (37%), including 42 children. Bronchoalveolar lavage (BAL) was performed on 68 occasions in 57 patients (six children). In 110 patients (36 children) with pneumonia, BAL was not performed. BAL contributed to the diagnosis in 43 cases (63%) and to relevant findings in 53 cases: bacteria (n=13, 24%), viruses (n=28, 53%) and fungi (n=12, 23%). In 25 cases BAL was negative. In 15 of these cases, BAL was performed >or=4 days after chest X-ray, and in four cases not in the same segment as the infiltrations. The median time between radiographic findings and positive BAL was 2 (0-15) days, and a negative BAL 6 (1-30) days (P<0.001). Antimicrobial treatment was administered to 79% patients with positive findings, and to 92% with negative findings at the time of BAL. No serious complications due to the procedure were reported. BAL resulted in a changed treatment in 32/68 (47%) episodes of pneumonia. To conclude, BAL is a safe and useful diagnostic procedure that should be performed early after the onset of pneumonia following allogeneic HSCT.

摘要

接受异基因造血干细胞移植 (HSCT) 的患者容易发生肺部感染。1998 年至 2004 年间,共有 450 名患者在卡罗林斯卡大学医院 Huddinge 接受了 HSCT。167 名患者(37%)被诊断患有肺炎,其中包括 42 名儿童。对 57 名患者(6 名儿童)进行了 68 次支气管肺泡灌洗 (BAL)。在 110 名患有肺炎的患者(36 名儿童)中,未进行 BAL。BAL 在 43 例(63%)中有助于诊断,并在 53 例中发现相关结果:细菌(n=13,24%)、病毒(n=28,53%)和真菌(n=12,23%)。25 例 BAL 为阴性。在这些病例中,有 15 例是在胸部 X 射线后 >或=4 天进行的 BAL,4 例不是在浸润的同一部位进行的。影像学发现与阳性 BAL 之间的中位时间为 2(0-15)天,阴性 BAL 为 6(1-30)天(P<0.001)。有阳性结果的患者中 79%接受了抗菌治疗,有阴性结果的患者中 92%在 BAL 时接受了抗菌治疗。未报告因该程序引起的严重并发症。BAL 使 32/68(47%)例肺炎的治疗发生了改变。总之,BAL 是一种安全且有用的诊断程序,应在异基因 HSCT 后肺炎发作后尽早进行。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验